Home
Information
European Medicines Agency Orphan Drug Status
Summary of Product Characteristics (SPC)
Technology
Clinical Development
Publications & Scientific Papers
Review Articles
Clinical Publications
Pre-Clinical Publications
Tools & Forms
Patient Informed Concent
Contact
Clinical Publications
Title
Date
A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/ neu–Negative Metastatic Breast Cancer
2011
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
2011
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
2010
Liposomal Cisplatin Dose Escalation for Determining the Maximum Tolerated Dose and Dose-limiting Toxicity: A Phase I Study
2010
Phase II study of liposomal cisplatin (LipoplatinTM) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
2009
CONCURRENT LIPOSOMAL CISPLATIN (LIPOPLATIN), 5-FLUOROURACIL AND RADIOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER: A PHASE I/II STUDY
2009
Response of a Patient with Pleural and Peritoneal Mesothelioma after Second-Line Chemotherapy with Lipoplatin and Gemcitabine
2008
First Safety and Response Results of a Randomized Phase III Study with Liposomal Platin in the Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
2008
Phase 1 Trial of Lipoplatin and Gemcitabine as a Second-line Chemotherapy in Patients With Nonsmall Cell Lung Carcinoma
2008
Jehn Lipoplatin-5FU SCCHN PHASE III
2007
Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: A phase I-Il study
2006
Liposomal Oxaliplatin in the Treatment of Advanced Cancer: A Phase I Study
2006
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study
2005
Systemic Lipoplatin Infusion Results in Preferential Tumor Uptake in Human Studies
2005
© 2018 Regulon Group - Lipoplatin is a licensed product of
Regulon Inc.